Dave Hickey serves as executive vice president and president of the Life Sciences segment of BD (Becton, Dickinson and Company), a leading global medical technology company headquartered in Franklin Lakes, New Jersey. In this role, he oversees the global operational, commercial and financial performance of the two businesses that comprise the Life Sciences segment: Integrated Diagnostic Solutions and BD Biosciences.
Hickey joined BD in 2014 as vice president and general manager for the Clinical Microbiology business. In 2016, he was promoted to president of the Diagnostics Systems business, and in 2019, to worldwide president of the newly formed Integrated Diagnostic Solutions unit, which brought together the strengths of the Diagnostic Systems and Preanalytical Systems businesses. Under Hickey’s leadership, IDS became instrumental in the global fight against SARS-CoV-2 (COVID-19), overseeing the development, launch, manufacturing and distribution of critical molecular and rapid point-of-care tests as well as critical swabs and viral transport systems.
Prior to BD, Hickey spent 22 years with Siemens Healthcare Diagnostics in multiple positions of increasing responsibility, including his last four years as CEO of its Central Laboratory Business Unit.
Dave is an active participant on the boards of directors for AdvaMedDx, Greater Baltimore Committee, Johns Hopkins Bloomberg School of Public Health, and the University of Maryland, Baltimore (UMB) Health Sciences Research Park.